Federica Sotgia PhD, FRSB
Vice-President of Lunella Biotech Inc.

Federica Sotgia is a distinguished biomedical scientist renowned for her contributions to cancer biology and aging research.

Dr. Sotgia earned her post-graduate degree (specialita’) in Medical Genetics from the University of Genova, Italy, in 2001. Following her doctorate, she pursued postdoctoral research at the Albert Einstein College of Medicine in New York, where she was later promoted to Instructor. In 2006, she was appointed Assistant Professor in the Department of Cancer Biology at the Kimmel Cancer Center, Thomas Jefferson University, in Philadelphia. In 2012, Dr. Sotgia joined the University of Manchester (UK) as a Senior Lecturer before assuming her role as a Professor and Chair in Cancer Biology and Ageing at the University of Salford, Manchester, in 2016.

Throughout her career, Dr. Sotgia has focused on the tumor microenvironment's role in cancer progression. Her research has provided genetic evidence that enhanced glycolysis in stromal cells supports tumorigenesis. Additionally, she has investigated the metabolic requirements of tumor-initiating cells and explored the repositioning of FDA-approved drugs to target these cells effectively.